Want to see JP:7840 full AI Analyst Report?
Top Page
France Bed Holdings Co., Ltd.
(7840)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥1,379.00
▲(6.32% Upside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by steady top-line growth and a generally manageable balance sheet, but tempered by weakening margins and a thinner, less consistent free-cash-flow profile. Technical signals are neutral-to-slightly positive, and valuation is supportive with a reasonable P/E and a ~3.23% dividend yield.
Positive Factors
Steady revenue growth
Sustained revenue expansion indicates resilient demand for bedding and healthcare products and services. Continued growth across the period supports the durability of the company’s market presence, including institutional and home-care channels.
Negative Factors
Margin and earnings deterioration
Falling EBITDA and net margins despite revenue growth indicate rising costs, unfavorable mix, or weaker operating efficiency. If persistent, this erosion could limit earnings growth and reduce the benefit of the company’s expanding sales base.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady revenue growth
Sustained revenue expansion indicates resilient demand for bedding and healthcare products and services. Continued growth across the period supports the durability of the company’s market presence, including institutional and home-care channels.
Read all positive factors
France Bed Holdings Co., Ltd. (7840) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥44.86B
Dividend Yield3.15%
Average Volume (3M)23.58K
Price to Earnings (P/E)14.9
Beta (1Y)0.36
Revenue Growth3.77%
EPS Growth8.09%
CountryJP
Employees1,834
SectorGeneral
Sector StrengthN/A
IndustryMedical - Specialties
Share Statistics
EPS (TTM)86.96
Shares Outstanding34,747,500
10 Day Avg. Volume26,760
30 Day Avg. Volume23,583
Financial Highlights & Ratios
PEG Ratio-4.17
Price to Book (P/B)1.08
Price to Sales (P/S)0.70
P/FCF Ratio36.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
France Bed Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
France Bed Holdings Co.,Ltd., through its subsidiaries, engages in the medical services and home furnishing and health businesses in Japan. It operates through the Medical Services Business and Home Furnishings and Health Business segments. The co...
How the Company Makes Money
France Bed Holdings generates revenue mainly through (1) sales of bedding and related products and (2) rental/leasing services tied to care and medical-use equipment. A core part of its earnings is derived from supplying hospitals, nursing-care fa...
France Bed Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
70
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.38B | 61.77B | 60.56B | 59.15B | 58.58B | 54.40B |
| Gross Profit | 34.23B | 33.81B | 33.06B | 31.89B | 31.19B | 29.00B |
| EBITDA | 9.79B | 9.60B | 10.00B | 10.39B | 10.28B | 9.49B |
| Net Income | 2.90B | 2.75B | 2.95B | 3.13B | 2.70B | 2.56B |
Balance Sheet | ||||||
| Total Assets | 68.17B | 67.75B | 70.89B | 68.58B | 64.68B | 64.30B |
| Cash, Cash Equivalents and Short-Term Investments | 16.25B | 14.86B | 17.22B | 16.70B | 12.86B | 11.28B |
| Total Debt | 12.54B | 17.20B | 17.21B | 18.32B | 14.34B | 15.39B |
| Total Liabilities | 28.28B | 27.58B | 30.28B | 30.36B | 26.55B | 26.75B |
| Stockholders Equity | 39.88B | 40.16B | 40.61B | 38.21B | 38.12B | 37.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.20B | 2.71B | 3.06B | 4.13B | -568.00M |
| Operating Cash Flow | 0.00 | 6.33B | 7.45B | 7.83B | 8.93B | 6.01B |
| Investing Cash Flow | 0.00 | -4.32B | -4.93B | -5.62B | -6.69B | -7.78B |
| Financing Cash Flow | 0.00 | -2.88B | -2.50B | 633.00M | -2.66B | 316.00M |
France Bed Holdings Co., Ltd. Technical Analysis
Positive
1297.00
Price Trends
1256.98
Positive
1265.61
Positive
1285.90
Positive
Market Momentum
7.97
Negative
61.02
Neutral
76.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7840, the sentiment is Positive. The current price of 1297 is above the 20-day moving average (MA) of 1269.65, above the 50-day MA of 1256.98, and above the 200-day MA of 1285.90, indicating a bullish trend. The MACD of 7.97 indicates Negative momentum. The RSI at 61.02 is Neutral, neither overbought nor oversold. The STOCH value of 76.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7840.
France Bed Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥186.26B | 11.32 | ― | 4.91% | 3.91% | 28.69% | |
73 Outperform | ¥195.51B | 13.64 | ― | 3.41% | 2.58% | 26.69% | |
67 Neutral | ¥44.86B | 14.95 | ― | 3.16% | 3.77% | 8.09% | |
62 Neutral | ¥139.93B | 12.68 | ― | 2.20% | 10.72% | 11.90% | |
56 Neutral | ¥3.44B | 7.79 | ― | 4.00% | 5.93% | -3.93% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ¥8.74B | -4.57 | ― | 2.65% | 2.16% | -194.33% |
* General Sector Average
JP:7840
France Bed Holdings Co., Ltd.
1,300.00
70.88
5.77%
JP:7791
DREAMBED CO.,LTD.
827.00
-27.12
-3.18%
JP:7898
Wood One Co., Ltd.
946.00
80.32
9.28%
JP:7972
Itoki Corporation
2,595.00
309.86
13.56%
JP:7981
Takara Standard Co., Ltd
3,115.00
562.72
22.05%
JP:8130
Sangetsu Corporation
3,210.00
278.88
9.51%
France Bed Holdings Co., Ltd. Corporate Events
France Bed boosts quarterly profits and reaffirms upbeat full-year outlook
Aug 7, 2026
France Bed Holdings reported consolidated net sales of ¥14.97 billion for the quarter ended June 30, 2026, up 4.2% year on year, with operating profit jumping 26.6% to ¥990 million and profit attributable to owners of parent rising 33.0%...
France Bed Completes Restricted Stock-Based Treasury Share Disposal for Executive Remuneration
Jul 22, 2026
France Bed Holdings has completed payment for the disposal of 4,300 shares of its treasury stock as restricted stock-based remuneration, following a board resolution passed on June 29, 2026. The shares, priced at 1,226 yen each for a total of 5,27...
France Bed to Grant Restricted Treasury Shares to Align Executive Pay With Performance
Jun 29, 2026
France Bed Holdings has approved the disposal of 4,300 shares of its treasury stock as restricted stock-based remuneration for one director of the parent company and two directors of a subsidiary, with a total disposal value of about ¥5.27 mi...
France Bed Lowers Conversion Price on 2029 Zero Coupon Convertible Bonds After Dividend Approval
Jun 24, 2026
France Bed Holdings Co., Ltd. has adjusted the conversion price of its zero coupon convertible bonds due 2029 from 1,317.1 yen to 1,293.4 yen, effective April 1, 2026 or later. The change reflects the company’s adherence to bond terms that l...
France Bed lifts dividend as profits dip, forecasts earnings rebound in FY2027
Jun 22, 2026
France Bed Holdings reported a modest 1.9% increase in consolidated net sales to ¥61.8 billion for the fiscal year ended March 31, 2026, but saw operating profit, ordinary profit, and profit attributable to owners of parent decline by 7.7%, 7...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.